Moberg Pharma AB (publ) Sustainability Profile
Moberg Pharma AB (publ), headquartered in Sweden, is a prominent player in the pharmaceutical industry, specialising in innovative healthcare solutions. Founded in 2006, the company has made significant strides in developing and commercialising products that address unmet medical needs, particularly in the fields of dermatology and pain management. With a strong focus on proprietary formulations, Moberg Pharma's core products include topical treatments that leverage unique delivery systems, setting them apart in a competitive market. The company has established a solid market position, recognised for its commitment to quality and efficacy. Notable achievements include successful partnerships and a growing international presence, particularly in Europe and North America, underscoring its role as a leader in the pharmaceutical landscape.
DitchCarbon Score
How does Moberg Pharma AB (publ)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Moberg Pharma AB (publ)'s score of 26 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Moberg Pharma AB (publ)'s reported carbon emissions
Moberg Pharma AB (publ), headquartered in Sweden (SE), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate commitments, including those aligned with the Science Based Targets initiative (SBTi) or other industry standards. As a result, Moberg Pharma's climate strategy and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company may need to establish clear climate commitments and reduction targets to align with industry best practices and enhance its sustainability profile.
How Carbon Intensive is Moberg Pharma AB (publ)'s Industry?
How Carbon Intensive is Moberg Pharma AB (publ)'s Location?
Moberg Pharma AB (publ)'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Moberg Pharma AB (publ) has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
